Sun Pharmaceutical Industries Ltd. has received the US FDA approval for its Abbreviated New Drug Application (ANDA) for generic version of Zyprexa, olanzapine tablets USP, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg.

These generic olanzapine tablets, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg are therapeutic equivalents of Eli Lilly’s Zyprexa tablets. Olanzapine tablets have annual sale of approximately $3.3 billion in the US.

Olanzapine tablets are indicated for the treatment of schizophrenia, bipolar I disorder (manic or mixed episodes).   Zyprexa is a registered trademark of Eli Lilly & Co.

Sun Pharmaceutical Industries Ltd. is an international, integrated, speciality pharmaceutical company. The company is a leader in niche therapy areas of psychiatry, neurology, cardiology, nephrology, gastroenterology, orthopedics and ophthalmology.